These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208 [TBL] [Abstract][Full Text] [Related]
27. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia. Thibaut F; Ribeyre JM; Dourmap N; Ménard JF; Dollfus S; Petit M Biol Psychiatry; 1998 Jan; 43(1):24-30. PubMed ID: 9442341 [TBL] [Abstract][Full Text] [Related]
28. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin. Maas JW; Contreras SA; Seleshi E; Bowden CL Arch Gen Psychiatry; 1988 Jun; 45(6):553-9. PubMed ID: 3377641 [TBL] [Abstract][Full Text] [Related]
29. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. Kendler KS; McGuire M; Gruenberg AM; Walsh D Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316 [TBL] [Abstract][Full Text] [Related]
30. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993 [TBL] [Abstract][Full Text] [Related]
31. Plasma and CSF HVA before and after pharmacological treatment. Sharma R; Javaid JI; Janicak P; Faull K; Comaty J; Davis JM Psychiatry Res; 1989 Apr; 28(1):97-104. PubMed ID: 2740469 [TBL] [Abstract][Full Text] [Related]
32. Positive and negative symptoms. Relation to familial transmission of schizophrenia. Baron M; Gruen RS; Romo-Gruen JM Br J Psychiatry; 1992 Nov; 161():610-4. PubMed ID: 1422608 [TBL] [Abstract][Full Text] [Related]
33. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Nibuya M; Kanba S; Sekiya U; Suzuki E; Matsuo Y; Kinoshita N; Shintani F; Yagi G; Asai M Biol Psychiatry; 1995 Jul; 38(1):50-6. PubMed ID: 7548472 [TBL] [Abstract][Full Text] [Related]
34. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. Cai HL; Fang PF; Li HD; Zhang XH; Hu L; Yang W; Ye HS Psychiatry Res; 2011 Jul; 188(2):197-202. PubMed ID: 21146875 [TBL] [Abstract][Full Text] [Related]
35. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309 [TBL] [Abstract][Full Text] [Related]
36. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Bowers MB; Mazure CM; Nelson JC; Jatlow PI Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190 [TBL] [Abstract][Full Text] [Related]
37. Remoxipride in schizophrenia. A preliminary report. den Boer JA; Verhoeven WM; Westenberg HG Acta Psychiatr Scand; 1986 Oct; 74(4):409-14. PubMed ID: 2880457 [TBL] [Abstract][Full Text] [Related]
38. Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients. Whelton CL; Gupta RN; Cleghorn JM; Ballagh SR Schizophr Res; 1993 Dec; 11(1):33-40. PubMed ID: 8297802 [TBL] [Abstract][Full Text] [Related]
39. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients. Sharma RP; Javaid JI; Pandey GN; Janicak PG; Davis JM Biol Psychiatry; 1991 Sep; 30(5):459-66. PubMed ID: 1657221 [TBL] [Abstract][Full Text] [Related]
40. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia. Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]